Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.
about
Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapyHepatitis B Virus genotypic differences map structurally close to NRTI resistance hot spotsEpidemiology study of HBV genotypes and antiviral drug resistance in multi-ethnic regions from Western China.Antiviral therapies: focus on hepatitis B reverse transcriptaseEmerging pipeline drugs for hepatitis B infection.Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues.A rationalized approach to the treatment of patients infected with hepatitis B.Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis.Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.Hepatitis B virus resistance substitutions: long-term analysis by next-generation sequencing.Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.Epidemiology of Acute Hepatitis B in the United States From Population-Based Surveillance, 2006-2011.HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D.Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.Assembly Properties of Hepatitis B Virus Core Protein Mutants Correlate with Their Resistance to Assembly-Directed Antivirals
P2860
Q30390865-057EC7CC-1A68-4B0F-98F0-B6EB4E8F8DDEQ35885547-17257610-1065-4493-BFFA-CFD3F1B21D0BQ36324370-B06445F6-CC89-4966-8540-05A4E16EB555Q36467514-1AEE9DDA-338A-45CF-BE17-FA3E65EC5EE2Q37971052-52781A12-511C-4921-9F04-F351C56F5EAFQ38074646-81D9972A-1E04-425C-9551-8F0CACF5E426Q38168105-1C8DCE6D-3530-4A67-A4EE-69EA21888621Q38260502-415D60C9-F850-4D88-8F43-1E4694495D69Q38408847-2AFDAD22-7750-4417-83D7-45443235ECFFQ40603516-BDC1C46D-D75D-4B0C-A642-70DF02182CDCQ40707320-2B551DEC-0A3F-4C33-90B6-F87F4E3C9985Q41026046-FE8B133D-2027-4EE7-8074-0DB0810D98C9Q42263082-6518009A-3C76-4563-96AF-13D2B68FB69FQ42990814-A594D03C-67D5-44FF-8D8B-C7E1D8A502DDQ48053718-ACCE75AD-6398-4D9A-B573-61F816DBCFD6Q55019535-E640FE67-A42C-4759-962D-824142F78A8FQ57445698-09D38C54-4470-42AE-B10D-645A1A26995D
P2860
Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Mutation pattern of lamivudine ...... e associated mutation pattern.
@en
Mutation pattern of lamivudine ...... e associated mutation pattern.
@nl
type
label
Mutation pattern of lamivudine ...... e associated mutation pattern.
@en
Mutation pattern of lamivudine ...... e associated mutation pattern.
@nl
prefLabel
Mutation pattern of lamivudine ...... e associated mutation pattern.
@en
Mutation pattern of lamivudine ...... e associated mutation pattern.
@nl
P2093
P2860
P356
P1476
Mutation pattern of lamivudine ...... ce associated mutation pattern
@en
P2093
Christine Walker
Hans Damerow
Hans L Tillmann
Johannes Wiegand
Lilly Yuen
Stephen Locarnini
P2860
P304
P356
10.1002/JMV.21902
P577
2010-11-01T00:00:00Z